OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Precision treatment in advanced hepatocellular carcinoma
Xupeng Yang, Chen Yang, Shu Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 180-197
Open Access | Times Cited: 112
Xupeng Yang, Chen Yang, Shu Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 180-197
Open Access | Times Cited: 112
Showing 26-50 of 112 citing articles:
Encoding the Intra- and Peri-Tumoral Heterogeneity of Hepatocellular Carcinoma for Micro-Vascular Invasion Prediction and Prognostic Risk Stratification: A Multicenter Study
Yunfei Zhang, Shutong Wang, Mingyue Song, et al.
(2025)
Closed Access
Yunfei Zhang, Shutong Wang, Mingyue Song, et al.
(2025)
Closed Access
Astragalus Polysaccharide Regulates Epithelial-mesenchymal Transition in HepG2 Liver Cancer Cells by Inhibiting NLRP3 Inflammasome Activation
Hongtao Sui, Xiangliang Yang, Zongyuan Huang, et al.
Pharmacognosy Magazine (2025)
Closed Access
Hongtao Sui, Xiangliang Yang, Zongyuan Huang, et al.
Pharmacognosy Magazine (2025)
Closed Access
Effect of Narrow-Margin Hepatectomy Combined with Intraoperative Radiotherapy on Long-Term Prognosis of Patients with Centrally Located Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Changcheng Tao, Liguo Liu, Nan Hu, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 261-274
Open Access
Changcheng Tao, Liguo Liu, Nan Hu, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 261-274
Open Access
Synergizing metabolomics and artificial intelligence for advancing precision oncology
Yipeng Xu, Xiao-Juan Jiang, Zeping Hu
Trends in Molecular Medicine (2025)
Closed Access
Yipeng Xu, Xiao-Juan Jiang, Zeping Hu
Trends in Molecular Medicine (2025)
Closed Access
MicroRNA-6069 ASO inhibits the growth of hepatocellular carcinoma by PLEKHO1
Yan Jiang, Juan Tan, Shan Liao, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2025) Vol. 1869, Iss. 4, pp. 130774-130774
Closed Access
Yan Jiang, Juan Tan, Shan Liao, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2025) Vol. 1869, Iss. 4, pp. 130774-130774
Closed Access
Potentiation of Sorafenib’s Action by Berberine via Suppression of the mTOR Signaling Pathway in Human Hepatoma Cells
Rongrong Zhang, Na Wang, Bo Fan, et al.
Nutrition and Cancer (2025), pp. 1-13
Closed Access
Rongrong Zhang, Na Wang, Bo Fan, et al.
Nutrition and Cancer (2025), pp. 1-13
Closed Access
A novel nomogram based on complement C3 to predict the overall survival of early-stage hepatocellular carcinoma patients with microvascular invasion-positive undergoing curative resection
Guoyi Xia, Ze‐Yan Yu, Shaolong Lu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Guoyi Xia, Ze‐Yan Yu, Shaolong Lu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Precision surgery for hepatocellular carcinoma
Christian Tibor Josef Magyar, Luckshi Rajendran, Zhihao Li, et al.
The Lancet. Gastroenterology & hepatology (2025)
Closed Access
Christian Tibor Josef Magyar, Luckshi Rajendran, Zhihao Li, et al.
The Lancet. Gastroenterology & hepatology (2025)
Closed Access
Development and validation of an Immune-related Gene-based model for predicting prognosis and immunotherapy outcomes in hepatocellular carcinoma patients
Peng-Hui You, Xiaoling Liu, Min Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Peng-Hui You, Xiaoling Liu, Min Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Management strategies for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Jeayeon Park, Su Jong Yu
The Ewha Medical Journal (2025) Vol. 48, Iss. 1
Open Access
Jeayeon Park, Su Jong Yu
The Ewha Medical Journal (2025) Vol. 48, Iss. 1
Open Access
Comparison of efficacy and safety of adjuvant therapies versus sorafenib in hepatocellular carcinoma: a systematic review and network meta-analysis
Wenying Quan, Hanifah Fazlin Zulkifli, Nazamid Saari, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Wenying Quan, Hanifah Fazlin Zulkifli, Nazamid Saari, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Progress in the Application of Novel Nanomaterials in Targeted Therapy for Liver Cancer
Xin Wei, Weihua Cao, Shiyu Wang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2623-2643
Open Access
Xin Wei, Weihua Cao, Shiyu Wang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2623-2643
Open Access
Histidine metabolism drives liver cancer progression via immune microenvironment modulation through metabolic reprogramming
Pengcheng Liu, Fuxin Huang, Peixu Lin, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Pengcheng Liu, Fuxin Huang, Peixu Lin, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Integrated network pharmacology, proteomics, molecular docking, and experiments in vivo and in vitro to explore the efficacy and potential mechanism of bufalin against hepatocellular carcinoma angiogenesis
Yuanchao Li, Lingwei Zhou, Kangkang Sun, et al.
Journal of Ethnopharmacology (2025) Vol. 345, pp. 119589-119589
Closed Access
Yuanchao Li, Lingwei Zhou, Kangkang Sun, et al.
Journal of Ethnopharmacology (2025) Vol. 345, pp. 119589-119589
Closed Access
Exosomes: A Promising Drug Delivery Tool in Hepatic Drug Delivery
Neha Kanojia, Komal Thapa, Thakur Gurjeet Singh, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106761-106761
Closed Access
Neha Kanojia, Komal Thapa, Thakur Gurjeet Singh, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106761-106761
Closed Access
FoxO1 as a Hub in Immunosenescence Induced by Hepatocellular Carcinoma and the Effect of Yangyin Fuzheng Jiedu Prescription
Yuqing Xie, Fengna Yan, Xiaoteng Ma, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1543-1560
Open Access
Yuqing Xie, Fengna Yan, Xiaoteng Ma, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1543-1560
Open Access
LTA4H improves the tumor microenvironment and prevents HCC progression via targeting the HNRNPA1/LTBP1/TGF-β axis
Shuai Yang, Xinyao Qiu, Ying‐Cheng Yang, et al.
Cell Reports Medicine (2025), pp. 102000-102000
Open Access
Shuai Yang, Xinyao Qiu, Ying‐Cheng Yang, et al.
Cell Reports Medicine (2025), pp. 102000-102000
Open Access
Erythromycin Repurposing for Hepatocellular Carcinoma Treatment: Targeting CD24 to Enhance Anti-Tumor Immunity
Mingguang Shao, Tiesuo Zhao, Qian Li, et al.
European Journal of Pharmacology (2025), pp. 177457-177457
Closed Access
Mingguang Shao, Tiesuo Zhao, Qian Li, et al.
European Journal of Pharmacology (2025), pp. 177457-177457
Closed Access
Multi-omics analysis revealed the novel role of NQO1 in microenvironment, prognosis and immunotherapy of hepatocellular carcinoma
Yamei Tang, Haihong Hu, Siyuan Chen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Yamei Tang, Haihong Hu, Siyuan Chen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
BAIAP2L2 facilitates hepatocellular carcinoma progression and immune evasion of via targeting JAK1-mediated pathway and PD-L1 expression
Zhiyue Xie, Yanxia Wu, Nan Peng, et al.
Cancer Gene Therapy (2025)
Closed Access
Zhiyue Xie, Yanxia Wu, Nan Peng, et al.
Cancer Gene Therapy (2025)
Closed Access
Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study
Xiaokun Chen, Xiangan Wu, Peng Wei, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 561-577
Open Access
Xiaokun Chen, Xiangan Wu, Peng Wei, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 561-577
Open Access
Hollow MnO2@PDLIM2 nanoplatforms inhibits hepatocellular carcinoma immune evasion and progression by regulating TBK1
Zhiyi Liu, Qinghe Hu, Jin Wang, et al.
Chemical Engineering Journal (2025), pp. 161835-161835
Closed Access
Zhiyi Liu, Qinghe Hu, Jin Wang, et al.
Chemical Engineering Journal (2025), pp. 161835-161835
Closed Access
ETV5-S100A9 feed-forward loop connecting HCC and MDSCs to shape the immunosuppressive tumour microenvironment
Carmen Chak‐Lui Wong, Chun‐Ming Wong
Gut (2025), pp. gutjnl-335078
Closed Access
Carmen Chak‐Lui Wong, Chun‐Ming Wong
Gut (2025), pp. gutjnl-335078
Closed Access
Prognostic value of neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma receiving curative therapies: a systematic review and meta-analysis
Jinxiang Peng, Haozhu Chen, Zhuang Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Jinxiang Peng, Haozhu Chen, Zhuang Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Design, molecular docking and biological study of novel phenoxyquinoline bearing pyrazole scaffolds as potent anticancer agents
Vadlamani Nagarjuna, Suresh Maddila, Ravikumar Kapavarapu, et al.
Journal of Molecular Structure (2025), pp. 142213-142213
Closed Access
Vadlamani Nagarjuna, Suresh Maddila, Ravikumar Kapavarapu, et al.
Journal of Molecular Structure (2025), pp. 142213-142213
Closed Access
